# Akso Health Group: overview AHG · Nasdaq · CIK 1702318 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/ahg.md) · [Financials](/companies/ahg/financials.md) · [Filings](/companies/ahg/filings.md) · [Insiders](/companies/ahg/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [6.3](/filings/0001104659-22-130935.md) | [13.2](/filings/0001213900-25-076862.md) | [2.4](/filings/0001213900-26-080868.md) | [14.8](/filings/0001213900-26-080868.md) | [13.8](/filings/0001213900-26-080868.md) | | Gross margin | % | [9.6%](/filings/0001013762-24-002658.md) | [9.6%](/filings/0001213900-25-076862.md) | [5.1%](/filings/0001213900-26-080868.md) | [(1.9%)](/filings/0001213900-26-080868.md) | [(0.1%)](/filings/0001213900-26-080868.md) | | Operating margin | % | [(51.7%)](/filings/0001013762-24-002658.md) | [(108.2%)](/filings/0001213900-25-076862.md) | [(357.8%)](/filings/0001213900-26-080868.md) | [(1125.4%)](/filings/0001213900-26-080868.md) | [(149.7%)](/filings/0001213900-26-080868.md) | | Net margin | % | [(267.0%)](/filings/0001013762-24-002658.md) | [(10.3%)](/filings/0001213900-25-076862.md) | [(391.8%)](/filings/0001213900-26-080868.md) | [(913.4%)](/filings/0001213900-26-080868.md) | [(135.0%)](/filings/0001213900-26-080868.md) | | Diluted EPS | $ per share | [(0.28)](/filings/0001013762-24-002658.md) | [(0.02)](/filings/0001213900-25-076862.md) | [0.07](/filings/0001213900-26-080868.md) | [0.16](/filings/0001213900-26-080868.md) | [0.01](/filings/0001213900-26-080868.md) | | Free cash flow | $m | [(8.6)](/filings/0001013762-24-002658.md) | not reported | not reported | [1.0](/filings/0001213900-26-080868.md) | [(12.8)](/filings/0001213900-26-080868.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ahg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $105.7k | 70,943 | | Reduced −27,455 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $76.6k | 51,403 | | Added +4,528 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $68.6k | 46,026 | | New +46,026 | | [SmartHarvest Portfolios, LLC](/funds/2066604.md) | 2026-06-30 | $66.7k | 44,755 | | Added +9,326 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $61.6k | 41,360 | | Added +10,123 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $22.3k | 14,973 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $15.0k | 10,064 | | Added +10,027 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $1.4k | 963 | | New +963 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.1k | 739 | | New +739 | | [HUNTINGTON NATIONAL BANK](/funds/49205.md) | 2026-06-30 | $624 | 419 | | New +419 | ## Recent filings [All 192 filings](/companies/ahg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-07-23 | 16:05 ET | [20-F](/filings/0001213900-26-080868.md) | Annual report of a foreign private issuer, period 2026-03-31 | 0001213900-26-080868 | | 2026-05-13 | 16:14 ET | [6-K](/filings/0001213900-26-055807.md) | Report of a foreign private issuer, period 2026-05-13 | 0001213900-26-055807 | | 2026-03-23 | 16:40 ET | [6-K](/filings/0001213900-26-032967.md) | Report of a foreign private issuer, period 2026-03-23 | 0001213900-26-032967 | | 2026-02-10 | 16:06 ET | [6-K](/filings/0001213900-26-014261.md) | Report of a foreign private issuer, period 2025-09-30 | 0001213900-26-014261 | | 2025-08-14 | 17:29 ET | [20-F](/filings/0001213900-25-076862.md) | Annual report of a foreign private issuer, period 2025-03-31 | 0001213900-25-076862 | | 2025-05-01 | 16:35 ET | [6-K](/filings/0001213900-25-038488.md) | Report of a foreign private issuer, period 2025-05-01 | 0001213900-25-038488 | | 2025-03-28 | 16:05 ET | [6-K](/filings/0001013762-25-004071.md) | Report of a foreign private issuer, period 2024-09-30 | 0001013762-25-004071 | | 2024-11-08 | 16:05 ET | [6-K](/filings/0001213900-24-095891.md) | Report of a foreign private issuer, period 2024-11-08 | 0001213900-24-095891 | | 2024-07-30 | 16:05 ET | [20-F](/filings/0001013762-24-002658.md) | Annual report of a foreign private issuer, period 2024-03-31 | 0001013762-24-002658 | | 2024-05-02 | 08:00 ET | [6-K](/filings/0001213900-24-038753.md) | Report of a foreign private issuer, period 2024-05-02 | 0001213900-24-038753 | ## Latest annual report [Form 20-F for the fiscal year ended Mar 31, 2026](/filings/0001213900-26-080868.md), filed Jul 23, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1702318 - Tickers: AHG - Exchange: Nasdaq - SIC code: 7389 Services-Business Services, NEC - State of incorporation: E9 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.